"Our new focus areas are to offer services related to mRNA, plasmid development, GMP manufacturing"
Bengaluru-based contract research, development and manufacturing organisation Syngene International has recently expanded its biomanufacturing capacity to address the growing demand for outsourced biologics manufacturing and encouraging growth in the biologics business. In addition, the company has adopted a multipronged approach to attract the right talent as a part of its expansion plans. Mahesh Bhalgat, Chief Operating Officer, Syngene International, shares more in this regard during a detailed interaction with BioSpectrum.
Source: biospectrumindia.com